We are live on ! Find out more
HWM

HighMark Wealth Management Portfolio holdings

AUM $246M
1-Year Est. Return 35.95%
This Fund
S&P 500
This Quarter Est. Return
-2.2%
1 Year Est. Return
+35.95%
3 Year Est. Return
+84.22%
5 Year Est. Return
+86.67%
10 Year Est. Return
–
AUM
$169M
AUM Growth
-$4.66M
Cap. Flow
+$2.74M
Cap. Flow %
1.62%
Top 10 Hldgs %
73.61%
Holding
610
New
35
Increased
156
Reduced
72
Closed
36

Top Buys

Rank Stock Value
1
ANAB icon
AnaptysBio
ANAB
+$1.53M
2
CNTA
Centessa Pharmaceuticals
CNTA
+$1.14M
3
AXGN icon
Axogen
AXGN
+$586K
4
TSLA icon
Tesla
TSLA
+$504K
5
PLRX icon
Pliant Therapeutics
PLRX
+$501K

Top Sells

Rank Stock Value
1
FNA
Paragon 28, Inc.
FNA
+$1.36M
2
NVDA icon
NVIDIA
NVDA
+$517K
3
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$409K
4
IWM icon
iShares Russell 2000 ETF
IWM
+$252K
5
PYCR
Paycor HCM, Inc. Common Stock
PYCR
+$144K

Sector Composition

Rank Sector Weight
1 Healthcare 15.33%
2 Financials 5.86%
3 Technology 3.53%
4 Industrials 1.51%
5 Consumer Discretionary 1.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSLA icon
26
Tesla
TSLA
$1.21T
$671K 0.4%
2,595
+1,513
+140% +$504K
CRNX icon
27
Crinetics Pharmaceuticals
CRNX
$8.88B
$671K 0.4%
19,995
– –
AMZN icon
28
Amazon
AMZN
$2.49T
$666K 0.39%
3,500
+57
+2% +$12.4K
AXGN icon
29
Axogen
AXGN
$2.18B
$661K 0.39%
35,735
+32,500
+1,005% +$586K
PG icon
30
Procter & Gamble
PG
$347B
$603K 0.36%
3,541
+18
+0.5% +$3.02K
ABT icon
31
Abbott
ABT
$183B
$569K 0.34%
4,299
+30
+0.7% +$3.82K
XEL icon
32
Xcel Energy
XEL
$50.4B
$524K 0.31%
7,403
-16
-0.2% -$1.09K
HSBC icon
33
HSBC
HSBC
$354B
$517K 0.31%
9,008
– –
ECL icon
34
Ecolab
ECL
$76.3B
$512K 0.3%
2,021
+5
+0.2% +$1.26K
TNDM icon
35
Tandem Diabetes Care
TNDM
$1.14B
$482K 0.28%
25,170
– –
COST icon
36
Costco
COST
$423B
$474K 0.28%
501
+116
+30% +$113K
INSM icon
37
Insmed
INSM
$22.8B
$459K 0.27%
6,010
– –
OEF icon
38
iShares S&P 100 ETF
OEF
$19.7B
$416K 0.25%
1,538
– –
XOM icon
39
ExxonMobil
XOM
$642B
$385K 0.23%
3,234
+157
+5% +$17.4K
BRK.B icon
40
Berkshire Hathaway Class B
BRK.B
$1.07T
$342K 0.2%
642
-55
-8% -$26.7K
MDXG icon
41
MiMedx Group
MDXG
$649M
$327K 0.19%
43,000
+40,000
+1,333% +$334K
VOO icon
42
Vanguard S&P 500 ETF
VOO
$966B
$322K 0.19%
627
+248
+65% +$134K
KRMD icon
43
KORU Medical Systems
KRMD
$185M
$307K 0.18%
120,935
– –
EVH icon
44
Evolent Health
EVH
$439M
$306K 0.18%
32,275
– –
VV icon
45
Vanguard Large-Cap ETF
VV
$51.7B
$300K 0.18%
1,167
-41
-3% -$11.1K
EFA icon
46
iShares MSCI EAFE ETF
EFA
$76.6B
$269K 0.16%
3,297
– –
SIBN icon
47
SI-BONE Inc
SIBN
$758M
$267K 0.16%
19,000
– –
IEFA icon
48
iShares Core MSCI EAFE ETF
IEFA
$187B
$252K 0.15%
3,334
-150
-4% -$11.2K
ADP icon
49
Automatic Data Processing
ADP
$103B
$242K 0.14%
792
– –
HEI icon
50
HEICO Corp
HEI
$49.6B
$242K 0.14%
904
– –
1
2
3 4 5

Similar funds

PPA
Pilgrim Partners Asia Singapore $246M AUM
IRP
Investment Research Partners Lemont, Pennsylvania $246M AUM
EPIM
Equinox Partners Investment Management Stamford, Connecticut $245M AUM 225.58% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
RPCONE
Retirement Planning Company of New England Warwick, Rhode Island $246M AUM 27.83% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $245M AUM 34.1% 1-Year Est. Return
VPA
Vernal Point Advisors San Francisco, California $246M AUM 12.97% 1-Year Est. Return

HighMark Wealth Management's Q1 2025 Portfolio in Review

As of Q1 2025, HighMark Wealth Management held 610 positions worth $169M, down 2.7% from $174M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

HighMark Wealth Management's Q1 2025 filing shows 35 new, 156 increased, 72 reduced and 36 closed positions. Its largest new stake was AnaptysBio: 92,000 shares worth $1.71M. The largest sale was Paragon 28, Inc., an estimated $1.36M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Financials and Technology.

  • HighMark Wealth Management's largest Q1 2025 buy was AnaptysBio: 92,000 shares worth $1.71M.
  • HighMark Wealth Management added most to Centessa Pharmaceuticals in Q1 2025, an estimated $1.14M increase.
  • HighMark Wealth Management's biggest Q1 2025 reduction was Paragon 28, Inc., cutting an estimated $1.36M.
  • HighMark Wealth Management fully exited Paycor HCM, Inc. Common Stock in Q1 2025, selling an estimated $144K.
  • HighMark Wealth Management's ten largest holdings make up 74% of its $169M portfolio in Q1 2025.
  • HighMark Wealth Management opened 35 new positions and closed 36 in Q1 2025.
  • HighMark Wealth Management's portfolio value fell 2.7% quarter-over-quarter to $169M.

Based on HighMark Wealth Management's 13F filing for Q1 2025, filed 24 Apr 2025.